⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12510241 | 1.00 | — | — | |
| SCHEMBL14375298 | 0.79 | — | — | |
| SCHEMBL3625540 | 0.67 | — | — | |
| SCHEMBL13201593 | 0.63 | — | — | |
| SCHEMBL2128814 | 0.63 | — | — | |
| SCHEMBL24202319 | 0.63 | — | — | |
| SCHEMBL194358 | 0.63 | — | — | |
| SCHEMBL13700695 | 0.63 | — | — | |
| SCHEMBL2128812 | 0.63 | — | — | |
| SCHEMBL12263878 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020023898-A1 | USE OF NEUROKININ-1 ANTAGONISTS TO TREAT CHRONIC PRURITUS | MENLO THERAPEUTICS INC. (US) | 2020-01-30 | — | — | WO | disclosed |